Transcode Therapeutics Semi Variance
| RNAZ Stock | | | USD 9.56 -0.12 -1.24% |
Observed values used to calculate the Semi Variance technical indicator for Transcode Therapeutics. Certain instruments may report limited data depending on market coverage.
Transcode Therapeutics has current Semi Variance of 23.81. Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level.
Semi Variance | = | SUM(RET DEV)2N(ZERO) |
| = | 23.81 | |
| SUM | = | Summation notation |
| RET DEV | = | Actual return deviation over selected period |
| N(ZERO) | = | Number of points with returns less than zero |
Semi Variance Peers Comparison
Semi Variance Relative To Other Indicators
Transcode Therapeutics is rated
fifth in semi variance among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about
1.50 of Maximum Drawdown per Semi Variance. At
1.50 , Transcode Therapeutics's Maximum Drawdown-to-Semi Variance multiple reflects the spread between these metrics
Semi-variance is the square of semi-deviation. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Compare Transcode Therapeutics to Peers
Other Technical Indicators